Grading City Hall: See our report card for L.A. City Council President Herb Wesson
Opinion Editorial

Fecal transplants: A therapy whose time has come

Clostridium difficile is a dangerous infection that, as its name implies, is not always easy to treat successfully with antibiotics. In many cases, the infection is actually triggered by antibiotic use during hospitalization; the medications kill beneficial bacteria that keep C. difficile in check.

Now, some doctors are treating the infection with a procedure called fecal transplant, an unappealing but extremely effective approach that involves transferring filtered stool from a healthy donor to a patient afflicted with the disease, to reintroduce the helpful gut bacteria. One randomized trial comparing fecal transplant with antibiotics was stopped early because the non-drug approach was so effective that it would have been unethical to continue treating the other patients with medication. Subsequent studies have placed the cure rate at about 90%; a doctor from Mayo Clinic in Arizona describes a hospital patient who had been bedridden for weeks with C. difficile being discharged within 24 hours of fecal transplant.

Last year, the FDA, concerned about how swiftly the practice was taking hold without oversight, announced that it considered donor feces an “investigational new drug,” which meant an application would have to be filed every time a doctor wanted to perform the procedure. The intent was to ensure the treatment's safety, but the time and trouble involved would have delayed treatment for very sick patients and might have discouraged some doctors from offering the transplant at all. In addition, the label didn't fit: Drugs are manufactured in factories where every aspect of their production can be standardized so that one pill is exactly like another. Stool is made by the human body and obviously isn't going to be all that standardized. Doctors, medical societies and the Centers for Disease Control and Prevention protested, and weeks later, the FDA withdrew from its earlier position.

Since then, though, fecal transplants have been in a regulatory gray area. The procedure is still being performed, but there are no real safety and oversight rules. Yet without agency regulation, how can it become an approved, standard therapy with accepted protocols? In addition, researchers would like to try the therapy as a possible treatment for other ailments such as inflammatory bowel disease, but the path toward experimental approval is unclear.

A group of scientists, writing in the journal Nature, proposed a solution the FDA should seriously consider: Define feces as human tissue, similar to blood or organs donated for transplant. Tissues must be tested to prevent the spread of disease, and careful records must be kept. Fecal transplant shouldn't be stigmatized as a semi-rogue procedure without strict safety rules; at the same time, the rules should be a good fit for this remarkably helpful treatment.

Copyright © 2015, Los Angeles Times
Related Content
  • 'Low T' and the peril of medicating grumpy old men

    'Low T' and the peril of medicating grumpy old men

    Treating 'low testosterone' may do more harm than good.

  • Got flu? Keep it to yourself.

    Got flu? Keep it to yourself.

    If you're sick enough to need medicine, do yourself and everyone else a favor: Just stay home.

  • The dirty secrets of antibacterial soap

    The dirty secrets of antibacterial soap

    Antibacterial soap is great stuff — if you’re talking about just plain old regular soap. Because all soap combats bacteria. It doesn’t need germ-killing chemicals added to do that. The difference is that regular soap doesn’t act so much to “kill” bacteria as it binds to it, removing it from our...

  • Senate maneuvering spares Planned Parenthood -- for now

    Senate maneuvering spares Planned Parenthood -- for now

    A series of hidden-camera videos by anti-abortion activists capturing Planned Parenthood executives discussing tissue harvesting from aborted fetuses has renewed calls by Republicans to eliminate all federal support for the organization. But as bad as it's been lately in Washington for Planned...

  • Fast-tracking VA firings makes for bad policy

    Fast-tracking VA firings makes for bad policy

    The scandals that rocked the federal Department of Veterans Affairs last year rightly had some high-reaching consequences, including toppling secretary Eric K. Shinseki. Whether Shinseki’s successor, Robert McDonald, has been able to effect much of a cultural change within the department that provides,...

  • Richard Henry Dana's second act

    Richard Henry Dana's second act

    Richard Henry Dana Jr. told no one that he was turning 28 because, he wrote on Aug. 1, 1843, “birthdays are not pleasant occasions for hilarity with me and friends always feel bound to make them so.” Nevertheless, I trust Dana would have been delighted to know that friends of his classic “Two Years...